The Company currently anticipates fiscal year 2025 consolidated net sales of approximately $925 million, ahead of its most recently issued guidance of approximately $920 million. Initial Fiscal Year ...
Good morning, and welcome to the USANA Health Sciences Second Quarter Earnings Call. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference over to your ...
The Company is issuing its initial net sales outlook for fiscal year 2026 in the range of $925 million to $1.0 billion. The Company’s initial fiscal 2026 net sales outlook reflects: Net sales from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results